Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Reminder to EHC National Member Organisations (NMOs): registration for the EHC New Technologies Conference 2026 is still open!
Joining us in Bucharest, Romania, from 30 October to 1 November 2026, this conference will bring together EHC NMOs and healthcare professionals for an in-depth look at the latest medical advancements in rare bleeding disorders, including the new technologies set to reach the European market in the coming years.
Places are limited to two representatives per NMO on a first-come, first-served basis.
EHC will cover registration, travel (economy fare), and accommodation costs for participants nominated by NMOs.
The registration link has been sent directly to NMOs by email.
Haven’t registered yet?
Act now — spots are filling up!
Full event details.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?
-
Sep 20, 2026, 00:50A Shared Platelet Factor 4–Targeted Immune Mechanism in Adenovirus Infection – NEJM